Average Co-Inventor Count = 1.71
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Fox Chase Cancer Center (4 from 81 patents)
2. Institute for Cancer Research (3 from 64 patents)
3. Institut Curie (1 from 154 patents)
4. Institut De Genetique Et De Biologie Moleculaire Et Cellulaire (1 from 1 patent)
5. Institute for Cancer Research D/b/a the Research Institute of Fox Chase Cancer Center (0 patent)
6. Institut De Genetique Et De Biologie Moleculaire Et Cellularire (0 patent)
8 patents:
1. 11883413 - Inhibition of thymine DNA glycosylase in the treatment of cancer
2. 11077121 - Inhibition of thymine DNA glycosylase in the treatment of cancer
3. 10220051 - Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer
4. 8927516 - Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer
5. 7829671 - Gene encoding a DNA repair enzyme and methods of use thereof
6. 7491807 - Gene encoding a DNA repair enzyme and methods of use thereof
7. 7208583 - Antibodies immunologically specific for a DNA repair endonuclease and methods of use thereof
8. 6599700 - Methods for detection of transition single-nucleotide polymorphisms